Компания Raffles Pharmaceuticals успешно завершила получение дополнительной лицензии на производство дабрафениба мезилата в рамках своей лицензионной программы на производство – ByDrug
2024年6月28日，广东莱佛士制药技术有限公司正式获得省、市药品监督管理局颁发的甲磺酸达拉非尼生产许可证。这一证书的获得，标志着莱佛士在甲磺酸达拉非尼药品生产领域的高标准质量体系和优越生产条件得到了官方的充分认可。
该文章暂未提取到完整正文，已从资讯列表和商品关联资讯中自动隐藏。你可以返回文章列表继续浏览其他内容。
Câu hỏi thường gặp
Which products are related to this article?
No strongly related product has been identified yet. The match updates automatically when the article or catalog changes.
How can I view the medicines discussed in this article?
Use the related product cards below the article to review available specifications, prices, product information, and reviews.
Does this article replace advice from a doctor or pharmacist?
No. This content is for general information and health education only. Follow the prescription and individual guidance provided by qualified healthcare professionals.
